{"id":110951,"date":"2023-07-28T16:55:05","date_gmt":"2023-07-28T16:55:05","guid":{"rendered":"https:\/\/learnexams.com\/blog\/?p=110951"},"modified":"2023-07-28T16:55:09","modified_gmt":"2023-07-28T16:55:09","slug":"nrnp-6560-final-exam-latest-2023-2024-version-2-exam-100-questions-and-correct-answers-verified-answerswalden-university","status":"publish","type":"post","link":"https:\/\/www.learnexams.com\/blog\/2023\/07\/28\/nrnp-6560-final-exam-latest-2023-2024-version-2-exam-100-questions-and-correct-answers-verified-answerswalden-university\/","title":{"rendered":"NRNP 6560 FINAL EXAM LATEST 2023-2024 VERSION 2 EXAM 100 QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS)WALDEN UNIVERSITY"},"content":{"rendered":"\n<p><a>EPAP<\/a><\/p>\n\n\n\n<p><a>expiratory positive airway pressure<\/a><\/p>\n\n\n\n<p><a>CPAP<\/a><\/p>\n\n\n\n<p><a>continuous positive airway pressure<br><br>a treatment for apnea involving keeping a patient&#8217;s airways open using air pressure delivered via a face mask<br><br>IPAP=EPAP<\/a><\/p>\n\n\n\n<p><a>ABCDE<\/a><\/p>\n\n\n\n<p><a>asymmetry, border, color, diameter &gt;6mm, evolving<\/a><\/p>\n\n\n\n<p><a>skin eruptions or exanthema 3 groups<\/a><\/p>\n\n\n\n<p><a>1. Macular and maculopapular lesions<br>2. vesicular or bullous lesions<br>3. pustular, petechial, or purpuric lesions<\/a><\/p>\n\n\n\n<p><a>secondary changes of skin lesions<\/a><\/p>\n\n\n\n<p><a>comedones, crusting, excoriation, lichenification, scales, scarring, telangiectasia<\/a><\/p>\n\n\n\n<p><a>acne<\/a><\/p>\n\n\n\n<p><a>inflammatory disease of the skin involving the sebaceous glands and hair follicles<br><br>causes: corticosteriods, isoniazid<\/a><\/p>\n\n\n\n<p><a>bullous lesions<\/a><\/p>\n\n\n\n<p><a>Caused by exfoliative toxins A and B<br>Have the appearance of wrinkled tissue paper<br>Lead to widespread desquamation of the skin<br>Patients are left vulnerable to secondary bacterial infections<br><br>causes: barbiturate overdose, penicillamine, sulfonamides<\/a><\/p>\n\n\n\n<p><a>eczematous dermatitis<\/a><\/p>\n\n\n\n<p><a>most common inflammatory skin disorder, several forms including irritant contact dermatitis allergic contact dermatitis and atopic dermatitis<br><br>causes: abx, methyldopa, phenylbutazone, sulfonamides<\/a><\/p>\n\n\n\n<p><a>erythemia multiforme<\/a><\/p>\n\n\n\n<p><a>Hypersensitivity reaction characterized by targetoid rash and bullae; *HSV and mycoplasma infections; EM with oral mucosa and fever is steven-johnson syndrome<br><br>causes: barbiturates, hydantois, penicillin, salicylates, sulfonamides, sulfonylureas<\/a><\/p>\n\n\n\n<p><a>erythema nodosum<\/a><\/p>\n\n\n\n<p><a>inflammation of subcutaneous tissues resulting in tender, erythematous nodules; may be an abnormal immune response to a systemic disease, an infection, or a drug<br><br>causes: contraceptives, sulfonamides<\/a><\/p>\n\n\n\n<p><a>exfoliative dermatitis<\/a><\/p>\n\n\n\n<p><a>a condition in which there is widespread scaling of the skin, often with pruritus, erythroderma, and hair loss<br><br>causes: allopurinal, gold, indomethacin, phenylbutazone<\/a><\/p>\n\n\n\n<p><a>lichenoid eruption<\/a><\/p>\n\n\n\n<p><a>violaceous to purple, polygonal lesions that resemble those seen in lichen planus<br><br>Causes: cholorquine, chlorpropamide, mepacrine, quinidine, quinine, thiazides<\/a><\/p>\n\n\n\n<p><a>photosensitivity<\/a><\/p>\n\n\n\n<p><a>increased reaction of the skin to exposure to sunlight<br><br>causes: amiodarone, nalidixic acid, sulfonamides, tetracycline<\/a><\/p>\n\n\n\n<p><a>pigmentation<\/a><\/p>\n\n\n\n<p><a>coloration caused by deposit, or lack, of colored material in the tissues<br><br>causes: chloroquine, heavy metals, mepacrine<\/a><\/p>\n\n\n\n<p><a>Psoriasiform rash<\/a><\/p>\n\n\n\n<p><a>causes: gold, methyldopa<\/a><\/p>\n\n\n\n<p><a>purpura<\/a><\/p>\n\n\n\n<p><a>multiple pinpoint hemorrhages and accumulation of blood under the skin<br><br>causes: cytotoxic drugs, meprobamate, quinidine, quinine<\/a><\/p>\n\n\n\n<p><a>systemic lupus erythematosus (SLE)<\/a><\/p>\n\n\n\n<p><a>chronic autoimmune inflammatory disease of collagen in skin, joints, and internal organs<br><br>causes: hydralazine, isoniazid, penicillamine, procainamide<\/a><\/p>\n\n\n\n<p><a>urticaria<\/a><\/p>\n\n\n\n<p><a>allergic reaction of the skin characterized by the eruption of pale red, elevated patches called wheals or hives<br><br>causes: aspirin, imipramine, penicillin, serum, toxoid, vaccines<\/a><\/p>\n\n\n\n<p><a>Bulla<\/a><\/p>\n\n\n\n<p><a>a large blister that is usually more than 0.5 cm in diameter<\/a><\/p>\n\n\n\n<p><a>Comedones<\/a><\/p>\n\n\n\n<p><a>plug of keratin and sebum wedged in a dilated pilosebaceous<\/a><\/p>\n\n\n\n<p><a>crust<\/a><\/p>\n\n\n\n<p><a>accumulated dried exudate<\/a><\/p>\n\n\n\n<p><a>Excoriation<\/a><\/p>\n\n\n\n<p><a>a superficial loss of skin, e.g., by scratching<\/a><\/p>\n\n\n\n<p><a>lichenification<\/a><\/p>\n\n\n\n<p><a>area of increased epidermal thickening with exaggerated skin markings, caused by constant rubbing (atopic eczema)<\/a><\/p>\n\n\n\n<p><a>keloid<\/a><\/p>\n\n\n\n<p><a>a sharply elevated, irregularly shaped, progressively enlarging scar due to excessive collagen formation in the dermis during connective tissue<\/a><\/p>\n\n\n\n<p><a>macule<\/a><\/p>\n\n\n\n<p><a>flat, colored spot on the skin<\/a><\/p>\n\n\n\n<p><a>nodule<\/a><\/p>\n\n\n\n<p><a>circumscribed, palpable area of the skin that is &gt;0.5 cm in diameter and appears in part or wholly within the dermis<\/a><\/p>\n\n\n\n<p><a>papule<\/a><\/p>\n\n\n\n<p><a>A circumscribed, solid elevation of skin &lt; 1cm in diameter, with no visible fluid<\/a><\/p>\n\n\n\n<p><a>patch<\/a><\/p>\n\n\n\n<p><a>large macule, &gt;2cm in diameter<\/a><\/p>\n\n\n\n<p><a>plaque<\/a><\/p>\n\n\n\n<p><a>circumscribed, disk-shaped elevated area of the skin &gt;1cm diameter<\/a><\/p>\n\n\n\n<p><a>purpura<\/a><\/p>\n\n\n\n<p><a>multiple pinpoint hemorrhages and accumulation of blood under the skin<\/a><\/p>\n\n\n\n<p><a>pustule<\/a><\/p>\n\n\n\n<p><a>raised spot on the skin containing pus<\/a><\/p>\n\n\n\n<p><a>scales<\/a><\/p>\n\n\n\n<p><a>flakes or dry patches made up of excess dead epidermal cells<\/a><\/p>\n\n\n\n<p><a>scar<\/a><\/p>\n\n\n\n<p><a>area of fibrous tissue that replaces the lost epidermis<\/a><\/p>\n\n\n\n<p><a>stria<\/a><\/p>\n\n\n\n<p><a>streak-like, linear, atrophic, pink, purple, or white lesion caused by stretching of the skin<\/a><\/p>\n\n\n\n<p><a>Telangiectasia<\/a><\/p>\n\n\n\n<p><a>skin lesion due to permanently enlarged and dilated blood vessels that are visible<\/a><\/p>\n\n\n\n<p><a>ulcer<\/a><\/p>\n\n\n\n<p><a>loss of epidermis and part or whole of the dermis<\/a><\/p>\n\n\n\n<p><a>vesicle<\/a><\/p>\n\n\n\n<p><a>visible accumulation of fluid beneath the epidermis (&lt;0.5 cm in diameter)<\/a><\/p>\n\n\n\n<p><a>weal<\/a><\/p>\n\n\n\n<p><a>circumscribed, elevated area of cutaneous edema<\/a><\/p>\n\n\n\n<p><a>Dermatitis Medicamentosa<\/a><\/p>\n\n\n\n<p><a>Hypersensitivity reaction to a drug.<br><br>onset is abrupt, widespread, and symmetric erythematous eruption<\/a><\/p>\n\n\n\n<p><a>type 1: immediate-type immunologic reaction<\/a><\/p>\n\n\n\n<p><a>IgE mediated<br>manifested by urticaria and angioedema of skin or mucosa, edema of other organ, and fall in BP (anaphylatic shock)<\/a><\/p>\n\n\n\n<p><a>Type 2: Cytotoxic reaction<\/a><\/p>\n\n\n\n<p><a>drug or causative agent causes lysis of cells, such as platelets or leukocytes, or may, by combo with another drug, produce antibodies (immune complexes) that causes lysis or phagocytosis<\/a><\/p>\n\n\n\n<p><a>type 3: serum sickness, drug-induced vasculitis<\/a><\/p>\n\n\n\n<p><a>IgG and IgM antibodies are formed against a drug<br>manifested by vasculitis, urticaria-like lesions, arthritis, nephritis, alveolitis, hemolytic anemia, thrombocytopenia, and agranulocytosis<\/a><\/p>\n\n\n\n<p><a>type 4: morbilliform (exanthematous) reaction<\/a><\/p>\n\n\n\n<p>cell-mediated immune reaction<br>sensitized lymphocytes react with the drug, releasing cytokines, resulting in cutaneous inflammatory response<br>Drug rash with eosinophilia syndrome (DRESS)<br>&#8211; present as hepatits, eosinophilia, pneumonia, lymphadenopathy, and nephritis<br>-symptoms may last 2-6 weeks after beginning the medication, most commonly associated with anticonvulsants, sulfonamines, beta blockers, antimicrobials, antidepressants, and allopurinal medication<\/p>\n\n\n\n<p><a>m\/c cause of urticaria and maculopapular allergic skin reaction<\/a><\/p>\n\n\n\n<p><a>penicillin-based medicaiton and trimethoprim-sulfamethoxazole<\/a><\/p>\n\n\n\n<p><a>penicillin-sensitive patients<\/a><\/p>\n\n\n\n<p><a>cephalosporins are assocaited with reaction in 5-15%<br>carbapenems 15-30%<\/a><\/p>\n\n\n\n<p><a>red man syndrome<\/a><\/p>\n\n\n\n<p><a>not an allergic reaction, associated with vanc often responds to slowing of infusion rate and administration of antihistamine<\/a><\/p>\n\n\n\n<p><a>ACE-I<\/a><\/p>\n\n\n\n<p><a>chronic cough and angioedema<\/a><\/p>\n\n\n\n<p><a>Beta Blockers<\/a><\/p>\n\n\n\n<p><a>precipitate asthma and should not be given to patients at high risk of anaphylaxis, BB may block the action of epi<\/a><\/p>\n\n\n\n<p><a>anticonvulsants and sulfonamines<\/a><\/p>\n\n\n\n<p><a>m\/c cause of toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS)<\/a><\/p>\n\n\n\n<p><a>radiocontrast media and opiois<\/a><\/p>\n\n\n\n<p><a>stimulate mast cell histamine release through a non-IgE-mediated mechanism<\/a><\/p>\n\n\n\n<p><a>lab and diagnostic for drug eruption<\/a><\/p>\n\n\n\n<p><a>LFT as a baseline<br>skin bx<br>allergy skin test<br>patch and photo test<br>challenge dosing<\/a><\/p>\n\n\n\n<p><a>Management of drug eruption<\/a><\/p>\n\n\n\n<p><a>withdrawal of drug<br>epi<br>antihistamines<\/a><\/p>\n\n\n\n<p><a>when does SJS or TEN usually occur<\/a><\/p>\n\n\n\n<p><a>during first 8 weeks of starting a new medicaiton<\/a><\/p>\n\n\n\n<p><a>m\/c medications to cause SJS or TEN<\/a><\/p>\n\n\n\n<p><a>allopurinol, lamotrigine, sulfonamines, sulfasalazine, nevirapine, and oxicams<\/a><\/p>\n\n\n\n<p><a>SCORTEN score<\/a><\/p>\n\n\n\n<p><a>prognosis of SJS\/TEN<br>seven variables with max score of 7<br>age 40 or greater = 1 pt<br>malignancy = 1 pt<br>body surface area detached greater than or equal to 10% = 1 pt<br>tachycardia greater or equal to 120 = 1 pt<br>serum urea &gt;10 = 1 pt<br>serum glucose &gt;14 = 1 pt<br>serum bicarb &lt;20 = 1 pt<\/a><\/p>\n\n\n\n<p><a>Treatment of SJS\/TEN<\/a><\/p>\n\n\n\n<p><a>discontinue agent asap<br>treat them as a burn patient &#8211; thermoregulation and electrolyte management<br>immunomodulation: cyclosporine, ATN agent, IVIG, plasmapheresis<\/a><\/p>\n\n\n\n<p><a>long term affects of SJS\/TEN<\/a><\/p>\n\n\n\n<p><a>eye disorders<br>vulvovaginal and urinary sequelae<\/a><\/p>\n\n\n\n<p><a>causative agent of cellulitis<\/a><\/p>\n\n\n\n<p><a>gram + cocci<br>group A B-hemolytic streptococci and staphylcococcus aureus<\/a><\/p>\n\n\n\n<p><a>risk factors for cellulitis<\/a><\/p>\n\n\n\n<p><a>prior trauma, underlying skin lesion, DM, pedal edema, venous and lymphatic compromise, IV drug use<\/a><\/p>\n\n\n\n<p><a>cellulitis of the L.E. of the elderly is often complicated by?<\/a><\/p>\n\n\n\n<p><a>DVT<\/a><\/p>\n\n\n\n<p><a>Gram negative rods causing cellulitis<\/a><\/p>\n\n\n\n<p><a>e. coli<\/a><\/p>\n\n\n\n<p><a>gram negative bacilli causing cellulitis in neutropenic and immunosuppressed patient<\/a><\/p>\n\n\n\n<p><a>serratia, proteus, enterobacter, and fungi (cryptococcus neoformans)<\/a><\/p>\n\n\n\n<p><a>Facial or upper extremity cellulitis<\/a><\/p>\n\n\n\n<p><a>H. influenzae<\/a><\/p>\n\n\n\n<p><a>patient with DM, cellulitis pathogens<\/a><\/p>\n\n\n\n<p><a>streptococci and staphylococci<\/a><\/p>\n\n\n\n<p><a>Erysipelothrix rhusiopathiae<\/a><\/p>\n\n\n\n<p><a>A cause of disease in swine, turkeys, and marine mammals, including diamond skin disease.<\/a><\/p>\n\n\n\n<p><a>Aeromonas<\/a><\/p>\n\n\n\n<p><a>gram negative bacillus; freshwater exposure<\/a><\/p>\n\n\n\n<p><a>vibrio<\/a><\/p>\n\n\n\n<p><a>salt water exposure<\/a><\/p>\n\n\n\n<p><a>confirm the diagnosis of cellulitis<\/a><\/p>\n\n\n\n<p><a>lymph node enlargement and lymphatic streaking (lymphangitis)<\/a><\/p>\n\n\n\n<p><a>differential diagnosis of cellulitis<\/a><\/p>\n\n\n\n<p><a>DVT and necrotizing fasciitis<\/a><\/p>\n\n\n\n<p><a>necrotizing fasciitis<\/a><\/p>\n\n\n\n<p><a>very toxic appearing, bullae, crepitus, anesthesia of the involed skin, overlying skin necrosis, evidence of rhabdomyolysis (elevated creatinine phosphokinase), disseminated intravascular coagulation<\/a><\/p>\n\n\n\n<p><a>management of cellulitis<\/a><\/p>\n\n\n\n<p><a>abx coverage for both streptococci and staphylococci<br>outpatient duration 5 days<br>Mild cellulitis (nonpurulent)<br>&#8211; penicillin V-K<br>&#8211; cephalexin<br>&#8211; Dicloxacillin<br>&#8211; allergy to penicillin: clindamycin or doxy<\/a><\/p>\n\n\n\n<p><a>CA-MRSA Cellulitis Treatment<\/a><\/p>\n\n\n\n<p><a>Doxy<br>TMP-SMX<br>Clindamycin<br>linezolid<\/a><\/p>\n\n\n\n<p><a>MSSA cellulitis treatment<\/a><\/p>\n\n\n\n<p><a>Dicloxacillin<br>cephalexin<br>TMP-SMX DS<\/a><\/p>\n\n\n\n<p><a>inpatient therapy for cellulitis<\/a><\/p>\n\n\n\n<p><a>nafcillin or oxacillin<br>cefazolin<\/a><\/p>\n\n\n\n<p><a>MRSA cellulitis inpatient therapy<\/a><\/p>\n\n\n\n<p><a>Vanc<br>linezolid<br>deptomycin<br>ceftaroline<br>treat till afebrile then outpatient treatment<br>&#8211; linezolid<br>&#8211; clindamycin<br>&#8211; TMP-SMX DS<\/a><\/p>\n\n\n\n<p><a>Immunocompromised Cellulitis treatment<\/a><\/p>\n\n\n\n<p><a>hospitalization and empiric abx<br>Vanc + antipseidomonal abx<br><br>&#8211; cefepime<br>&#8211; zosyn<br>&#8211; imipenem-cilastatin<br>&#8211; meropenem<\/a><\/p>\n\n\n\n<p><a>Erysipelothrix cellulitis treatment<\/a><\/p>\n\n\n\n<p><a>penicillin, cephalexin, clindamycin<\/a><\/p>\n\n\n\n<p><a>Vibrio species cellulitis treatment<\/a><\/p>\n\n\n\n<p><a>doxy + ceftriaxone<\/a><\/p>\n\n\n\n<p><a>aeromonas hydrophila cellulitis treatment<\/a><\/p>\n\n\n\n<p><a>doxy + ceftriaxone or cipro<\/a><\/p>\n\n\n\n<p><a>Tinea (skin infection) treatment<\/a><\/p>\n\n\n\n<p><a>terbinafine hydrochloride 1%<br>butenafine 1%<\/a><\/p>\n\n\n\n<p><a>recurrence cellulitis caused by MSSA treatment<\/a><\/p>\n\n\n\n<p><a>long-term low dose Penicillin G<\/a><\/p>\n\n\n\n<p><a>recurrence cellulitis caused by MRSA treatment<\/a><\/p>\n\n\n\n<p><a>long-term low dose clindamycin<\/a><\/p>\n\n\n\n<p><a>herpes zoster (shingles)<\/a><\/p>\n\n\n\n<p><a>a disease that involves a painful, blistering rash accompanied by headache, fever, and a general feeling of unwellness<\/a><\/p>\n\n\n\n<p><a>herpes zoster lab\/diagnostics<\/a><\/p>\n\n\n\n<p><a>polymerase chain reaction testing, Tzanck smear<\/a><\/p>\n\n\n\n<p><a>ophthalmic zoster<\/a><\/p>\n\n\n\n<p><a>5th cranial nerve involvement:&nbsp;<strong>tip of the nose<\/strong>&nbsp;(emergency)<\/a><\/p>\n\n\n\n<p><a>50-50-50 rule<\/a><\/p>\n\n\n\n<p><a>guide for antiviral therapy<br>&lt; 50 hrs since onset of lesions<br>&gt; 50 years<br>&gt; 50 lesions<\/a><\/p>\n\n\n\n<p><a>antiviral for herpes zoster treatment<\/a><\/p>\n\n\n\n<p><a>acyclovir<br>valacyclovir<\/a><\/p>\n\n\n\n<p><a>acyclovir-resistance varicella-zoster virus treatment<\/a><\/p>\n\n\n\n<p><a>foscarnet<\/a><\/p>\n\n\n\n<p><a>adjunct therapy for Herpes Zoster treatment<\/a><\/p>\n\n\n\n<p><a>tylenol, cold compress, tramadol, opioids, oral corticosteriods, hydroxyzine (pruritus)<\/a><\/p>\n\n\n\n<p><a>PHN treatment<\/a><\/p>\n\n\n\n<p><a>Lidocaine or capsaicin skin patch<br>Gabapentin (Gralise, Horizant, Neurontin) and pregabalin (Lyrica)<br>Antidepressants \u2014 such as nortriptyline (Pamelor), amitriptyline, duloxetine (Cymbalta) and venlafaxine (Effexor XR) can be effective<\/a><\/p>\n\n\n\n<p><a>Prevention of herpes zoster<\/a><\/p>\n\n\n\n<p><a>Zoster vaccine indicated in all patients above 60<br>-Zoster vaccine live<br>-recombinant zoster vaccine<br><br>should not be administered to immunocompromised patient or pregnant women<\/a><\/p>\n\n\n\n<p><a>m\/c type of Skin cancer in the US<\/a><\/p>\n\n\n\n<p><a>basal cell carcinoma<\/a><\/p>\n\n\n\n<p><a>basal cell carcinoma (BCC)<\/a><\/p>\n\n\n\n<p><a>malignant tumor of the basal layer of the epidermis;<br>papule or nodule with a central scab or eroded area. Nodule has a waxy &#8220;pearly&#8221; appearance<\/a><\/p>\n\n\n\n<p><a>squamous cell carcinoma<\/a><\/p>\n\n\n\n<p><a>nonhealing ulcer or wart-like nodule<br>found on skin-exposed areas in fair-skin people<br>may develop from actinic keratosis<br>malignant tumor or epithelial keratinocytes<br>&#8211; capacity to metastize<br>&#8211; usually the result of exogenous carcinogens<\/a><\/p>\n\n\n\n<p><a>BCC predisposing factors<\/a><\/p>\n\n\n\n<p><a>sun exposure<br>arsenic exposure<br>m\/c on face and neck<\/a><\/p>\n\n\n\n<p><a>SCC predisposing factors<\/a><\/p>\n\n\n\n<p><a>M-F ration 2:1<br>SCC of lip, temple, ear, oral cavity, tongue, and genitalia have a higher rate of metastasis<br>smokers have increased risk for lip involvement<br>legs of females<br>HPV<\/a><\/p>\n\n\n\n<p><a>BCC characteristics<\/a><\/p>\n\n\n\n<p><a>noldules, papules, non-healing ulcers, or scabbed lesions<br>waxy, pearly nodules with telangiectatic vessels, or as visual or scaly plaques<br>borders are translucent, elevated, and shiny with fine telangiectasia<\/a><\/p>\n\n\n\n<p><a>SCC characteristics<\/a><\/p>\n\n\n\n<p>scaly, red, hard nodular, crusty, does not heal<br>usually asymptomatic<br>firm, skin-colored to reddish-brown nodules on damaged skin<br>may arise out of actinic keratosis<br>central ulceration<br>scaling and crusting<br>heaped-up edges of lesions appear fleshy rather than clear<br>lesion on the lower lip appear as firm, whitish macules<\/p>\n\n\n\n<p><a>lab\/diagnostics for BCC and SCC<\/a><\/p>\n\n\n\n<p><a>bx, shaved or punch bx<\/a><\/p>\n\n\n\n<p><a>BCC and SCC management<\/a><\/p>\n\n\n\n<p><a>dermatologist referral<br>bx<br>curettage and electrodesiccation of BCC lesion &lt;1cm in diameter and in nonfacial area<br><br>BCC follow up &#8211; annually for 5 years<br>SCC &#8211; every 3 months with close exam of lymph nodes for 1 year then twice a year after that<\/a><\/p>\n\n\n\n<p><a>Melanoma<\/a><\/p>\n\n\n\n<p><a>dark, pigmentation; may be flat or raised irregular borders; may be red, black, or bluish in color; size &gt;6 mm<br>develop from benign melanocytic cells<\/a><\/p>\n\n\n\n<p><a>Melanoma predisposing factors<\/a><\/p>\n\n\n\n<p><a>leading cause of death from skin cancer<br>preventative measure &#8211; avoidance of blistering solar radiation and use of sunscreen<br>fair skin, freckles, blonde, blue eyes<\/a><\/p>\n\n\n\n<p><a>melanoma characterisics<\/a><\/p>\n\n\n\n<p><a>bleeding and ulceration are ominous signs<br>scaling<br>texture change and irregular border<br>size change &gt;6mm<br>development of inflammation<br>color change<br>itching<\/a><\/p>\n\n\n\n<p><a>Six Signs of Malignant Melanoma (ABCDEEF<\/a><\/p>\n\n\n\n<p><a>Assymetry, Border, Color, Diameter, Elevation, Enlargement, Friend<\/a><\/p>\n\n\n\n<p><a>primary malignant melanomas<\/a><\/p>\n\n\n\n<p><a>superficial spreading &#8211; m\/c, caucasians<br>lentigo maligna<br>nodular malignant<br>acral lentiginous &#8211; palms, soles, and nail beds, more common in darkly pigmented people<br>malignant melanoma on mucous membrane<br>amelanotic (nonpigmented)<br>arising from blue nevi<br>congenital and giant nevocytic nevi<\/a><\/p>\n\n\n\n<p><a>labs\/diagnostics for melanoma<\/a><\/p>\n\n\n\n<p><a>surgical bx<br>should never be curetted, electrodesiccated, or shaved<br>sentinel lymph node bx for staging<\/a><\/p>\n\n\n\n<p><a>Staging of melanoma<\/a><\/p>\n\n\n\n<p><a>Stage I-II = Tumor (depth)<br>Stage III = Node involvement<br>Stage IV = Metastases<\/a><\/p>\n\n\n\n<p><a>management of melanomas<\/a><\/p>\n\n\n\n<p><a>dermatologist referral<br>follow up 3-6 months with skin exam<br>self exam skin weekly<\/a><\/p>\n\n\n\n<p><a>FAST<\/a><\/p>\n\n\n\n<p><a>face drooping, arm weakness, speech difficulty, Time to call 911<\/a><\/p>\n\n\n\n<p><a>LAPSS<\/a><\/p>\n\n\n\n<p><a>Los Angeles Prehospital Stroke Screen<\/a><\/p>\n\n\n\n<p><a>VAN assessment<\/a><\/p>\n\n\n\n<p><a>Vision, aphasia, neglect<\/a><\/p>\n\n\n\n<p><a>RACE<\/a><\/p>\n\n\n\n<p><a>Rapid arterial oCclusion Evaluation<\/a><\/p>\n\n\n\n<p><a>Lacunar stroke<\/a><\/p>\n\n\n\n<p><a>small subcortical infarcts &lt;15mm diameter<br>basal ganglia, internal capsule, thalamus, corona radiata, and pons<\/a><\/p>\n\n\n\n<p><a>sxs of lacunar stroke<\/a><\/p>\n\n\n\n<p><a>hemiparesis or heiplegia<br>dysarthria and dysphagia<\/a><\/p>\n\n\n\n<p><a>Ataxic hemiparesis<\/a><\/p>\n\n\n\n<p><a>lacunar stroke of the anterior limb of internal capsule or PONS base<br><br>weakness and ataxia on ipsi side of body, usually leg weakness more than arm<\/a><\/p>\n\n\n\n<p><a>Stoke BP control<\/a><\/p>\n\n\n\n<p><a>lowering BP initially by 15% during first 24 hr<\/a><\/p>\n\n\n\n<p><a>tPA BP limits<\/a><\/p>\n\n\n\n<p><a>prior SBP &lt;185 DBP &lt;110<br>during and after &lt;180 and DBP &lt;105<\/a><\/p>\n\n\n\n<p><a>Cryptogenic stroke<\/a><\/p>\n\n\n\n<p><a>an ischemic stroke whose cause cannot be attributed to a specific source of embolism, thrombosis, or small artery disease even with extensive medical testing<\/a><\/p>\n\n\n\n<p><a>hemorrhagic stroke<\/a><\/p>\n\n\n\n<p><a>occurs when a blood vessel in the brain leaks or ruptures; also known as a bleed<\/a><\/p>\n\n\n\n<p><a>hemorrhagic stroke symptoms<\/a><\/p>\n\n\n\n<p><a>Impaired LOC, headache, nausea\/vomiting, mobility, speech patterns, one sided weakness, blood pressure, respiratory status, pulse rate<\/a><\/p>\n\n\n\n<p><a>risk factors for hemorrhagic stroke<\/a><\/p>\n\n\n\n<p><a>HTN, cerebral amyloid angiopathy, anticoag or thrombolytic use, street drugs, heavy alcohol use, hematologic disorders, OTC stimulants\/energy drinks<\/a><\/p>\n\n\n\n<p><a>leading cause of ICH in &gt;60 y.o.<\/a><\/p>\n\n\n\n<p><a>cerebral amyloid angiopathy<\/a><\/p>\n\n\n\n<p><a>subarachnoid hemorrhage<\/a><\/p>\n\n\n\n<p><a>&#8220;Worst headache of my life&#8221;<\/a><\/p>\n\n\n\n<p><a>Hunt and Hess Scale<\/a><\/p>\n\n\n\n<p><a>predictor of mortality presenting with subarachnoid hemorrhage<br><br>1- no symptoms<br>2- CN palsy, HA, nuchal rigidity<br>3- mild focal deficit, lethargy, confusion<br>4- stupor, moderate\/severe hemiparesis<br>5- deep coma<\/a><\/p>\n\n\n\n<p><a>Fisher Grade<\/a><\/p>\n\n\n\n<p><a>Predicts vasospasm risk d\/t SAH based on CT scan<br>1 &#8211; no hemorrhage<br>4 &#8211; SAH with IPH and IVH<\/a><\/p>\n\n\n\n<p><a>intracerebral hemorrhage<\/a><\/p>\n\n\n\n<p><a>AIS and ICH<\/a><\/p>\n\n\n\n<p><a>basal ganglia hemorrhage<\/a><\/p>\n\n\n\n<p><a>Contralateral hemiparesis and hemisensory loss<br>ipsilateral Homonymous hemianopsia<br>ipsilateral Gaze palsy<br>decreased LOC<\/a><\/p>\n\n\n\n<p><a>Thalamic hemorrhage<\/a><\/p>\n\n\n\n<p><a>downward deviation of the eyes<br>pupils pinpoint with positive reaction<br>coma<br>flaccid quadriplegia<\/a><\/p>\n\n\n\n<p><a>Cerebellar hemorrhage<\/a><\/p>\n\n\n\n<p><a>NO HEMIPARESIS<br>facial weakness, ataxia, nystagmus, occipital headache, neck stiffness<br>ipsilateral horizontal conjugate gaze paresis<br>pupils PERRLA<br>inability to walk<br>vertigo and dysarthria<\/a><\/p>\n\n\n\n<p><a>formula for estimating ICH hematoma volume<\/a><\/p>\n\n\n\n<p><a>ABC\/2<br>(AxBxC)\/2<br>A=longest axis<br>B=longest axis perpendicular to A<br>C=# of slices x slice thickness<\/a><\/p>\n\n\n\n<p><a>management of ICH\/SAH<\/a><\/p>\n\n\n\n<p>avoid ketamine<br>succinylcholine can cause transient ICP increase<br>rocuronium is a neuromuscular blocking agent<br>BP control SBP &lt;140<br>Cerebral perfusion pressure (MAP-ICP)<br>correction of coagulopathy (if INR &gt;4)<br>check INR q 3-6 hr for first 24 hr<br>External ventricular drain placement (GCS &lt;9)<br>goal ICP &lt;20 and a CPP &gt;60<br>strict bed rest<br>cardiac monitoring<br>no straining<br>seizures<br>cerebral edema (mannitol)<br>check serum osmolality and Na+ q8hr<\/p>\n\n\n\n<p><a>management of aneurysm<\/a><\/p>\n\n\n\n<p><a>surgical clipping or endovascular coiling ASAP<\/a><\/p>\n\n\n\n<p><a>cerebral vasospasm<\/a><\/p>\n\n\n\n<p><a>can occur before or after aneurism clipping and coiling; administer calcium channel blocker nimodipine (Nimotop);<\/a><\/p>\n\n\n\n<p><a>re-bleeding<\/a><\/p>\n\n\n\n<p><a>occurs between 2-19 days after initial rupture<br>repeat CT scan and occasionally repeat LP is needed to confirm re-bleed<\/a><\/p>\n\n\n\n<p><a>Cerebral salt wasting<\/a><\/p>\n\n\n\n<p><a>hyponatremia, excessive secretion of natriuretic peptides<br>crystalloid fluid replacement<br>3% saline solution to correct hyponatremia 30-60 ml\/hr<br>q8 hr serum osmolality and Na+<br>fludrocortisone<\/a><\/p>\n\n\n\n<p><a>m\/c medical complication in aneurysmal SAH<\/a><\/p>\n\n\n\n<p><a>fever<\/a><\/p>\n\n\n\n<p><a>blast injury<\/a><\/p>\n\n\n\n<p><a>hippocampus and brain stem<\/a><\/p>\n\n\n\n<p><a>prehospital\/emergancy department treatment for TBI<\/a><\/p>\n\n\n\n<p><a>ACLS<br>spinal immobilization<br>GCS &lt;8 intubation<br>avoid hypoxemia o2 sat &gt;90 PaO2 &gt;60<br>avoid hyperventilation: goal ETCO2 or PaCO2 35-45<\/a><\/p>\n\n\n\n<p><a>avoid hyperventilation in TBI unless:<\/a><\/p>\n\n\n\n<p><a>herniation symptoms are present of if measured ICP is severely high<\/a><\/p>\n\n\n\n<p><a>AVPU<\/a><\/p>\n\n\n\n<p><a>Awake, responsive to voice, responsive to pain, unresponsive<\/a><\/p>\n\n\n\n<p><a>Decorticate posturing<\/a><\/p>\n\n\n\n<p><a>characterized by upper extremities flexed at the elbows and held closely to the body and lower extremities that are externally rotated and extended. occurs when the brainstem is not inhibited by the motor function of the cerebral cortex.<\/a><\/p>\n\n\n\n<p><a>Decerebrate posturing<\/a><\/p>\n\n\n\n<p><a>posturing in which the neck is extended with jaw clenched; arms are pronated, extended, and close to the sides; legs are extended straight out; more ominous sign of brain stem damage. Most Severe.<\/a><\/p>\n\n\n\n<p><a>lab studies for TBI<\/a><\/p>\n\n\n\n<p><a>toxicology drug and alcohol, CBC, chemistry, coagulation<\/a><\/p>\n\n\n\n<p><a>primary head injury<\/a><\/p>\n\n\n\n<p><a>involves features that occur at the time of trauma, including fractured skull, contusions, intracranial hematoma, and diffuse injury. Secondary complications include hypoxic brain damage, increased ICP, infection, cerebral edema, and posttraumatic syndromes.<\/a><\/p>\n\n\n\n<p><a>basilar fracture signs<\/a><\/p>\n\n\n\n<p><a>anterior or posterior skull base<\/a><\/p>\n\n\n\n<p><a>Sx&#8217;s of basilar skull fracture<\/a><\/p>\n\n\n\n<p><a>CN dysfunction<br>hemotympanum<br>battle sign &#8211; mastoid ecchymosis<br>raccoon eyes &#8211; periorbital ecchymosis<br>CSF leaking from ear or nose &#8211; + dextrostix, halo sign, salty taste in mouth, beta-2 transferrin<br>hearing loss<\/a><\/p>\n\n\n\n<p><a>brain injury<\/a><\/p>\n\n\n\n<p><a>concussion, contusion, hematoma, subdural hematoma, traumatic subarachnoid hemorrhage, diffuse axonal injury<\/a><\/p>\n\n\n\n<p><a>concussion<\/a><\/p>\n\n\n\n<p><a>coup-contrcoup injuries; m\/c found in the temporal lobe<\/a><\/p>\n\n\n\n<p><a>contusion<\/a><\/p>\n\n\n\n<p><a>m\/c seen lesions are in the orbitofrontal or anterior temporal regions<\/a><\/p>\n\n\n\n<p><a>Hematoma<\/a><\/p>\n\n\n\n<p><a>epidural: m\/c in the temporal\/parietal region<br>Subdural hematoma: m\/c caused by tearing of the bridging veins<\/a><\/p>\n\n\n\n<p><a>acute subdural hematoma sxs<\/a><\/p>\n\n\n\n<p><a>drowsiness, agitation, and confusion<br>HA<br>unilateral or bilateral pupil dilatation<br>hemiparesis<br>noncontrast CT<br>sx indications: &gt;10mm thickness with &gt;5mm midline shift regardless of GCS<\/a><\/p>\n\n\n\n<p><a>chronic subdural hematoma sxs<\/a><\/p>\n\n\n\n<p><a>HA<br>memory loss<br>personality changes<br>incontinence<br>ataxia<br>obtain CT scan<br>sx usually required, burr holes or craniotomy<\/a><\/p>\n\n\n\n<p><a>traumatic subarachnoid hemorrhage<\/a><\/p>\n\n\n\n<p><a>HA<br>reduced LOC<br>nuchal rigidity<br>hemiplegia<br>ipsilateral pupillary abnormalities<br>delayed vasospasm<\/a><\/p>\n\n\n\n<p><a>diffuse axonal injury<\/a><\/p>\n\n\n\n<p><a>type of brain injury characterized by shearing, stretching, or tearing of nerve fibers with subsequent axonal damage.<\/a><\/p>\n\n\n\n<p><a>penetrating head trauma abx<\/a><\/p>\n\n\n\n<p><a>ceftriaxone, metronidazole, and vanc immediately for minimum of 6 weeks<\/a><\/p>\n\n\n\n<p><a>management of TBI<\/a><\/p>\n\n\n\n<p><a>limit secondary injury<br>cerebral\/elevated ICP\/herniation<\/a><\/p>\n\n\n\n<p><a>herniation<\/a><\/p>\n\n\n\n<p><a>indicated by pupillary dilation<br>cushing triad: HTN, decreased RR, bradycardia, late finding of elevated ICP<\/a><\/p>\n\n\n\n<p><a>barbiturate coma<\/a><\/p>\n\n\n\n<p><a>may be used to treat ICP after admit; Reduces Metabolic Demand<br>Pentobarbital<\/a><\/p>\n\n\n\n<p><a>hyperosmolar therapy<\/a><\/p>\n\n\n\n<p><a>mannitol<br>serum osmolarity: maintain &lt;320<br>hypertonic saline (2%,3%, or 23% NaCl)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EPAP expiratory positive airway pressure CPAP continuous positive airway pressure a treatment for apnea involving keeping a patient&#8217;s airways open using air pressure delivered via a face mask IPAP=EPAP ABCDE asymmetry, border, color, diameter &gt;6mm, evolving skin eruptions or exanthema 3 groups 1. Macular and maculopapular lesions2. vesicular or bullous lesions3. pustular, petechial, or purpuric [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[],"tags":[],"class_list":["post-110951","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts\/110951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/comments?post=110951"}],"version-history":[{"count":0,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts\/110951\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/media?parent=110951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/categories?post=110951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/tags?post=110951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}